Notes on MPN Mutations
An interview with Nicolaus Kroeger, MD
Germline and somatic events combine to create myeloproliferative neoplasms.
23andMe spit initiative and Jakafi
John Mascarenhas: Novel therapeutic approaches in myelofibrosis (The paper)
An interview with Ross Levine, MD, PhD
CRISPR/Cas9 Off target activity
Considering stem cell transplant
Patient information: Treating with IFN-alph2
How I treat MPNs. (Hasselbalch, H.C.)
Aspirin and thrombotic complications in ET and PV
Polycythemia Vera — the lack of consensus
The MPNclinic Roundtable: How I diagnose MPNs.
(Mesa, Verstovsek, Gotlib, Silver,Hasselbalch, Orazi, Levine)
Clinical implications of diagnostic discrepancies in myelofibrosis
Michiels on Dameshek — the evolving view of polycythemia vera